VERU INC. Recognition of Deferred Revenue
VERU INC. (VERU) reported Recognition of Deferred Revenue of $18.62 thousand for the 9-month period ending 2014-06-30, per its 10-Q filed 2014-07-31.
Discontinued › Income Statement › Other Income
us-gaap:RecognitionOfDeferredRevenue · last filed 2014-07-31
- VERU INC. recognition of deferred revenue for the quarter ending 2014-06-30 was $6.21K, a 0.00% change year-over-year.
- VERU INC. recognition of deferred revenue for the quarter ending 2014-03-31 was $6.21K, a 0.00% change year-over-year.
- VERU INC. recognition of deferred revenue for the quarter ending 2013-12-31 was $6.21K, a 0.00% change year-over-year.
- VERU INC. recognition of deferred revenue for the quarter ending 2013-09-30 was $6.21K, a 0.00% change year-over-year.
- VERU INC. recognition of deferred revenue for fiscal 2013 was $24.83K, a 0.00% change from fiscal 2012.
- VERU INC. recognition of deferred revenue for fiscal 2012 was $24.83K, a 0.00% change from fiscal 2011.
- VERU INC. recognition of deferred revenue for fiscal 2011 was $24.83K, a 0.00% change from fiscal 2010.
- VERU INC. recognition of deferred revenue for fiscal 2010 was $24.83K, a 2.62% increase from fiscal 2009.
| Period end | Recognition of Deferred Revenue 3 month | Recognition of Deferred Revenue 6 month | Recognition of Deferred Revenue 9 month | Recognition of Deferred Revenue 9 month as first filed | Recognition of Deferred Revenue 12 month |
|---|---|---|---|---|---|
| 2014-06-30 | $6.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-31 | $12.41K derived: sum of 2 quarters · filed 2014-07-31 | $18.62K 10-Q · filed 2014-07-31 | $24.83K derived: sum of 4 quarters · filed 2014-07-31 | |
| 2014-03-31 | $6.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-01 | $12.42K 10-Q · filed 2014-05-01 | $18.62K derived: sum of 3 quarters · filed 2014-05-01 | $24.83K derived: sum of 4 quarters · filed 2014-07-31 | |
| 2013-12-31 | $6.21K 10-Q · filed 2014-02-03 | $12.42K derived: sum of 2 quarters · filed 2014-02-03 | $18.62K derived: sum of 3 quarters · filed 2014-07-31 | $24.83K derived: sum of 4 quarters · filed 2014-07-31 | |
| 2013-09-30 | $6.21K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-03 | $12.41K derived: sum of 2 quarters · filed 2014-07-31 | $18.62K derived: sum of 3 quarters · filed 2014-07-31 | $24.83K 10-K · filed 2013-12-03 | |
| 2013-06-30 | $6.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-31 | $12.41K derived: sum of 2 quarters · filed 2014-07-31 | $18.62K 10-Q · filed 2014-07-31 | $24.83K derived: sum of 4 quarters · filed 2014-07-31 | |
| 2013-03-31 | $6.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-01 | $12.42K 10-Q · filed 2014-05-01 | $18.62K derived: sum of 3 quarters · filed 2014-05-01 | $24.83K derived: sum of 4 quarters · filed 2014-05-01 | |
| 2012-12-31 | $6.21K 10-Q · filed 2014-02-03 | $12.42K derived: sum of 2 quarters · filed 2014-02-03 | $18.62K derived: sum of 3 quarters · filed 2014-02-03 | $24.83K derived: sum of 4 quarters · filed 2014-02-03 | |
| 2012-09-30 | $6.21K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-03 | $12.41K derived: sum of 2 quarters · filed 2013-12-03 | $18.62K derived: sum of 3 quarters · filed 2013-12-03 | $24.83K 10-K · filed 2013-12-03 | |
| 2012-06-30 | $6.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-01 | $12.41K derived: sum of 2 quarters · filed 2013-08-01 | $18.62K 10-Q · filed 2013-08-01 | $24.83K derived: sum of 4 quarters · filed 2013-12-03 | |
| 2012-03-31 | $6.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-02 | $12.42K 10-Q · filed 2013-05-02 | $18.62K derived: sum of 3 quarters · filed 2013-12-03 | $24.83K derived: sum of 4 quarters · filed 2013-12-03 | |
| 2011-12-31 | $6.21K 10-Q · filed 2013-01-30 | $12.42K derived: sum of 2 quarters · filed 2013-12-03 | $18.62K derived: sum of 3 quarters · filed 2013-12-03 | $24.83K derived: sum of 4 quarters · filed 2013-12-03 | |
| 2011-09-30 | $6.21K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-03 | $12.41K derived: sum of 2 quarters · filed 2013-12-03 | $18.62K derived: sum of 3 quarters · filed 2013-12-03 | $24.83K 10-K · filed 2013-12-03 | |
| 2011-06-30 | $6.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-07-31 | $12.41K derived: sum of 2 quarters · filed 2012-07-31 | $18.62K 10-Q · filed 2012-07-31 | -$18.62K 10-Q · filed 2011-08-05 | $62.08K derived: sum of 4 quarters · filed 2012-12-04 |
| 2011-03-31 | $6.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-01 | $12.42K 10-Q · filed 2012-05-01 | $55.87K derived: sum of 3 quarters · filed 2012-12-04 | ||
| 2010-12-31 | $6.21K 10-Q · filed 2012-01-31 | $49.66K derived: sum of 2 quarters · filed 2012-12-04 | |||
| 2010-09-30 | $43.45K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-04 | $24.83K 10-K · filed 2012-12-04 | |||
| 2010-06-30 | -$18.62K 10-Q · filed 2011-08-05 | ||||
| 2009-09-30 | $24.20K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |